Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, Kenny K.K., Zhang, Yi, Lim, Kah Leong, Tanaka, Yuji, Huang, Hui, Gao, Jun, Ross, Christopher A., Dawson, Valina L. +1 more·2001·Nature Medicine
DOI 10.1038/nm1001-1144

Cited by (744)

Items 701–744 of 744

  1. Yeast Cells as a Discovery Platform for Parkinson's Disease and other Protein Misfolding Diseases
    Karen L. Allendoerfer, Linhui Julie Su, Susan Lee Lindquist · 2008 · Elsevier eBooks
  2. The Neurobiology of Aging
    Tomohiro Nakamura, Malene Hansen, Sean Oldham, Stuart A. Lipton · 2010 · Elsevier eBooks
  3. Ubiquitin Localization Changes as C. elegans Undergo Stress
    Jacob T. Sanders · 2016
  4. Gene-Environment Interactions Between Manganese Toxicity and Early-Onset Parkinson's Disease Genes
    Sudipta Chakraborty · 2015
  5. The Lewy body dementias
    Richard Ronan Murphy, James B. Leverenz · 2016 · Cambridge University Press eBooks
  6. Endocytosis and Synaptic Function
    Sandra‐Fausia Soukup, Patrik Verstreken, Sven Vilain · 2017 · Elsevier eBooks
  7. Protein Oxidation, Quality-Control Mechanisms and Parkinson’s Disease
    Pablo Hernández-Franco, Annadurai Anandhan, Rodrigo Franco · 2017 · Royal Society of Chemistry eBooks
  8. PARK1 and α-Synuclein
    J. William Langston, Lawrence I. Golbe, Seung‐Jae Lee · 2003 · Elsevier eBooks
  9. Axonal Transport, Parkin, And Α-Synuclein; Novel Therapeutic Targets To Treat Methamphetamine Neurotoxicity
    Bryan A. Killinger · 2017 · Human Biology
  10. Multivariate Analysis to Identify Potential Biomarkers for Prognosis and Treatment Resistance in Head and Neck Cancer Patients
    Christina A. Wicker · 2018 · UKnowledge (University of Kentucky)
  11. Assessment of Nonmotor Symptoms in Rodent Models of Parkinson’s Disease
    Francesca Rossi, Manolo Carta, Elisabetta Tronci · 2020 · Neuromethods
  12. Zebrafish : a new model of Parkinson's disease
    Tomás Lopes da Fonseca · 2010 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  13. A REVIEW ON PARKINSON’S DISEASE: AN OVERVIEW
    Edwin Edwin · 2021
  14. EFFICACY OF TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) AND DUAL TASK TRAINING IN PARKINSON’S DISEASE
    Smati Sambyal, Sandeep Karhail, Shivam Monga · 2021 · PARIPEX-INDIAN JOURNAL OF RESEARCH
  15. Excitatory Amino Acids, S-Nitrosylation, and Protein Misfolding in Neurodegenerative
    Stuart A. Lipton, Tomohiro Nakamura · 2009 · Oxidative stress and disease
  16. Parkin and Neurodegeneration
    Sathya R. Sriram, Valina Lynn Dawson, Ted M. Dawson · 2007 · Wiley eBooks
  17. The Molecular Pathway to Neurodegeneration in Parkin‐Related Parkinsonism
    Ryōsuke Takahashi · 2007 · Wiley eBooks
  18. News in brief
    Natalie Baderman, JOANNE B. CLOUGH, Joanna Milburn, Joanna Owens · 2001 · Drug Discovery Today
  19. Parkinson Disease
    Nobutaka Hattori, Yoshikuni Mizuno · 2006 · Wiley eBooks
  20. 5. Recent Topics and Progress in Treatment of Parkinson's Disease
    Shigeki Kuzuhara · 2009 · Nihon Naika Gakkai Zasshi
  21. Mechanisms of Aggresome Biogenesis: Ubiquitination, Transport, & Maintenance
    AJ Keefe · 2019 · Preprints.org
  22. Photobiomodulation Therapy for Parkinson’s Disease
    Farzad Salehpour, Saeed Sadigh‐Eteghad, Javad Mahmoudi, Farzin Kamari, Paolo Cassano, Michael Richard Hamblin · 2023 · Synthesis lectures on biomedical engineering
  23. Synphilin-1 as a modulator of aSyn assembly
    Diana F. Lázaro, Triana Amen, Ellen Gerhardt, Patrícia I. Santos, Dragomir Milovanović, Günter U. Höglinger, Tiago F. Outeiro · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Characterization of the Phosphomimetic Mutant Y39E of a-Synuclein
    Nicola Martina Böffinger · 2024
  25. Cannabis sativa extracts reduce inclusion formation in a cell model of alpha-synuclein aggregation
    Tamires de Almeida Cruz, Rodrigo de Paulo Osorio, Neide Mara de Menezes Epifânio, Madiha Mohieldin Merghani, Marcos Dias Pereira, Douglas Siqueira de Almeida Chaves, Tiago F. Outeiro, Cristiano Jorge Riger · 2025 · Fitoterapia
  26. Additional file 4 of VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
    Xi Chen, Elpida Tsika, Nathan D. Levine, Darren J. Moore · 2023 · Figshare
  27. Additional file 3 of VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
    Xi Chen, Elpida Tsika, Nathan D. Levine, Darren J. Moore · 2023 · Figshare
  28. Additional file 1 of VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
    Xi Chen, Elpida Tsika, Nathan D. Levine, Darren J. Moore · 2023 · Figshare
  29. Additional file 2 of VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
    Xi Chen, Elpida Tsika, Nathan D. Levine, Darren J. Moore · 2023 · Figshare
  30. The parkin-γ-tubulin axis regulates epidermal homeostasis and is associated with the susceptibility to psoriasis
    Yuanyuan Liu, Shaoze Yan, Jiaxuan Wang, Dan Dong, Shaodong Yan, Hanxiao Yin, Kai Liu, Min Liu, Hong Liu, Dengwen Li et al. · 2026 · Cell Death and Differentiation
  31. LRRK2 et fonction mitochondriale dans la maladie de Parkinson : rôle dans la régulation de la mitophagie dépendante de la voie PINK1/Parkine
    Fiona Bonello · 2018 · theses.fr (ABES)
  32. Systematic characterization of a large number of Microtubule-Associated Proteins using purification-free TIRF-reconstitution assays
    A. S. Jijumon · 2021 · theses.fr (ABES)
  33. Neural cell state modulation by PARK2 and dopaminergic neuroprotection by small molecule Parkin agonism
    Yongxing Gong, Armin Bayati, Tyler Joseph Alban, Prerana Bangalore Parthasarathy, Fang Zhou, Vladimir Makarov, Yuhang Zhao, Chien‐Wen Su, Jackson G. Schumacher, Vijay Singh et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Evaluation of the role of parkin in the direct and indirect transcriptional regulation of alpha-synucléine in Parkinson's disease
    Lígia Ramos dos Santos · 2023 · theses.fr (ABES)
  35. Rôle de la Parkine dans la propagation tumorale liée à la gliomagenèse : études translationnelles in vitro et in vivo
    Aurore Bernardin · 2023 · theses.fr (ABES)
  36. Zebrafish Models of Parkinson’s Disease: From Pathogenesis to Drug Discovery
    Hae‐Chul Park, Yongbo Seo, Yeo Jeong Han, Su Hee Cho, Myung Ji Kim · 2026 · International Journal of Molecular Sciences
  37. Emerging insight in genetics and therapies in young-onset Parkinson’s disease (YOPD): a comprehensive review
    Grace E. Hey, Hikaru Kamo, Gilberto Perez Rodriguez Garcia, Peter Hedera, Adolfo Ramirez‐Zamora · 2026 · Journal of Neurology
  38. MicroRNA: role in pathogenesis, problems of microRNA therapy, and future prospects
    Elena V. Kugaevskaya, O S Timoshenko, Tatiana A. Gureeva, Alexander V. Lisitsa · 2026 · Biomeditsinskaya Khimiya
  39. PARK7/HSPB1-Mediated Neuroprotective Effects of SHED in an In vitro Parkinson’s Disease Model
    YiQi YU, Hongyu Chen, Jinglei Zheng, Shuting Liu, Xiao Wang, Cencan Xing, Hongwu Du · 2026 · Neurochemical Research
  40. Disease-specific glycosylation in the neurodegenerative brain
    Meredith Edwards, Natasha Vassileff, Joern R Steinert, Jereme G. Spiers · 2026 · Elsevier eBooks
  41. Common pesticides and the development of Parkinson's disease
    Rizwan Nisar · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  42. Neurogenetics in Parkinson's Disease
    Yoshikuni Mizuno, Nobutaka Hattori · 2007 · Springer eBooks
  43. Heat Shock Proteins in Brain Function
    Péter Csermely · 2006 · Springer eBooks
  44. Targeting α-Synuclein as a Parkinson’s Disease Therapeutic
    Luke Esposito · 2014 · Topics in medicinal chemistry